Loss of immune control is suspected as a factor in many cancers, melanoma among them. In recent research, investigators for on 25 genes differing in melanoma patients from those in healthy patients, and most of these genes were interferon-stimulating. The findings could help streamline treatments, and also may point in a specific direction for additional cancer research.